Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection-Reference-Cited by-同舟云学术

Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection

Published:2020-01-29 Issue:11 Volume:104 Page:2403-2414
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Lichvar Alicia B.,Tremblay Simon,Leino Abbie D.,Shields Adele R.,Cardi Michael A.,Abu Jawdeh Bassam G.,Govil Amit,Kremer Joseph,Cuffy Madison,Paterno Flavio,Diwan Tayyab,Brailey Paul,Girnita Alin,Alloway Rita R.,Woodle E. Steve

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference32 articles.

1. Quantifying renal allograft loss following early antibody-mediated rejection.;Orandi;Am J Transplant,2015

2. Time course of patdologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.;Bagnasco;Transplantation,2014

3. Tde significance of tde anti-class I antibody response. I. Clinical and patdologic features of anti-class I-mediated rejection.;Halloran;Transplantation,1990

4. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.;Amico;Transplantation,2009

5. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.;Gloor;Am J Transplant,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept;Clinical Immunology;2024-07

2. Carfilzomib‐based antibody mediated rejection therapy in pediatric kidney transplant recipients;Pediatric Transplantation;2023-05-02

3. Influence of Donor Race and Donor-recipient Race-matching on Pediatric Kidney Transplant Outcomes;Transplantation Direct;2022-05-09

4. Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation;Transplant International;2022-04-11

5. Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated Rejection;Frontiers in Medicine;2022-01-31